Elderly patients at highest risk with acute myocardial infarction are more frequently transferred from community hospitals to tertiary centers: Reality or myth?

American Heart Journal

Volumn 138, Issue 4 I, 1999, Pages 688-695

  Mehta, R H ^a   Stalhandske, E J ^a   McCargar, P A ^a   Ruane, T J ^a   Eagle, K A ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; COMMUNITY HOSPITAL; COMORBIDITY; ELDERLY CARE; FEMALE; FIBRINOLYTIC THERAPY; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; PATIENT TRANSPORT; PREDICTION AND FORECASTING; PRIORITY JOURNAL;

EID: 0032888269     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70184-5     Document Type: Article

References (45)

1. Graves EJ. 1988 Summary: National Hospital Discharge Survey: advance data from vital and statistics. Hyattsville, Md: National Center for Health Statistics; 1990. Publication No. 185.
2. National Heart, Lung, and Blood Institute. Morbidity and mortality: chartbook on cardiovascular, lung and blood diseases. Bethesda, Md: US Department of Health and Human Services, Public Health Service, National Institutes of Health; May 1992.
3. Herlitz J, Blohm M, Hatford M, et al. Delay time in suspected acute myocardial infarction and the importance of its modification. Clin Cardiol 1989;12:370-4.
4. GISSI-2. A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction. Lancet 1990;336:65-71.
5. ISIS-3 Collaborative Group. ISIS-3: a randomized comparison of streptokinase versus tissue plasminogen activator versus anistreplase and of aspirin plus heparin versus aspirin alone among 41299 cases of suspected acute myocardial infarction. Lancet 1992;339:753-70.
6. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
7. Taylor GJ, Mikell FL, Moses HW, et al. Intravenous versus intracoronary streptokinase therapy for acute myocardial infarction in community hospitals. Am J Cardiol 1984;54:256-60.
8. McNamara CA, Burklet MW, Brewster PS, et al. Comparison of thrombolytic therapy for acute myocardial infarction in rural and urban settings. Am J Med 1987;82:1095-101.
9. Sutton JM, Taylor GJ, Mikell FL, et al. Thrombolytic therapy followed by early revascularization for acute myocardial infarction. Am J Cardiol 1986;57:1227-31.
10. Topol EJ, Bates ER, Walton JA Jr, et al. Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction: improved timing, thrombolytic efficacy and ventricular function. J Am Coll Cardiol 1987;10:1173-7.
11. Stomel RJ, Rasak M, Bates ER. Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital. Chest 1994;105:997-1002.
12. Vogel RA. HCFA's Cooperative Cardiovascular Project: a nationwide quality assessment of acute myocardial infarction. Clin Cardiol 1994;17:354-6.
13. Fortune GJ, Gelletta S. The Cooperative Cardiovascular Project in Missouri. Mo Med 1996;93:600-3.
14. Ellerbeck EF, Jencks SF, Radford MJ, et al. Quality of care for Medicare patients with acute myocardial infarction: a 4-state pilot study from the Cooperative Cardiovascular Project. JAMA 1995;273:1509-14.
15. Allison JJ, Kiefe CI, Centor RM, et al. Racial differences in the medical treatment of elderly Medicare patients with acute myocardial infarction. J Gen Intern Med 1996;11:736-43.
16. American Hospital Association. Hospital Statistics. Chicago, Ill: American Hospital Association; 1992.
17. Udvarhelyi IS, Gatsonis C, Epstein AM, et al. Acute myocardial infarction in the Medicare population: process of care and clinical outcomes. JAMA 1992;268:2530-6.
18. Maggionni AP, Maseri A, Fresco C, et al. Age-related increase in mortality among patients with first myocardial infarction treated with thrombolysis: GISSI-2 Investigators. N Engl J Med 1993;329:1442-8.
19. Gurwitz JH, Goldberg RJ, Chen Z, et al. Recent trends in hospital mortality of acute myocardial infarction-the Worcester Heart Attack Study: have improvements been realized for all age groups? Arch Intern Med 1994;154:2202-8.
20. Tofler GH, Stone PH, Muller JE, et al. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly for black women. J Am Coll Cardiol 1987;9:473-82.
21. Greenland P, Reicher-Reiss H, Goldbourt U, et al, and the Israeli SPRINT Investigators. Women after myocardial infarction. Circulation 1991;83:484-91.
22. Fiebach NH, Viscoli CM, Horwitz RI. Differences between women and men in survival after myocardial infarction. JAMA 1990;263:1092-6.
23. Dittrich J, Gilpin E, Nicod P, et al. Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol 1988;62:1-7.
24. Stone PH, Muller JE, Hartwell T, et al. The effect of diabetes mellitus on the prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and left ventricular dysfunction to adverse prognosis: the MILIS Study Group. J Am Coll Cardiol 1989;14:49-57.
25. Smith JW, Marcus FL, Serokman R. Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol 1984;54:718-21.
26. Norris RM, Brandt PWT, Caughey DE, et al. A new coronary prognostic index. Lancet 1969;1:274-8.
27. Lee KL, Woodlief LH, Topol EJ, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an International Trial of 41021 patients. Circulation 1995;91:1659-68.
28. Knaus WA, Draper EA, Wagner DP, et al. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 1985;13:818-29.
29. Daley J, Jencks S, Drapes D, et al. Predicting hospital-associated mortality for Medicare patients: a method for patients with stroke, pneumonia, acute myocardial infarction, and congestive heart failure. JAMA 1988;260:3611-6.
30. Grines CL, Topol EJ, O'Neill WW, et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995;91:298-303.
31. Muller DWM, Topol EJ, Ellis SG, et al. Determinants of the need for early acute intervention in patients treated conservatively after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 1991;18:1594-601.
32. Lincoff AM, Topol EJ. Illusion of reperfusion: does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 1993;87:1792-805.
33. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction Study group. N Engl J Med 1993;328:673-89.
34. Zijlstra F, de Boer MJ, Hoorntje JC, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4.
35. Gurwitz JH, Gore JM, Goldberg RJ, et al, for the Participants in the National Registry of Myocardial Infarction. Recent age-related trends in the use of thrombolytic therapy in patients who have had myocardial infarction. Ann Intern Med 1996;124:283-91.
36. Rosamond WD, Shahar E, McGovern PG, et al. Trends in coronary thrombolytic therapy for acute myocardial infarction (The Minnesota Heart Survey Registry, 1990 to 1993). Am J Cardiol 1996;78:271-7.
37. Tobin JN, Wassertheir-Smoller S, Wexler JP, et al. Sex bias in considering coronary artery bypass surgery. Ann Intern Med 1987;107:19-25.
38. Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary artery disease. N Engl J Med 1991;325:221-5.
39. Steingart RM, Packer M, Hamm P, et al. Sex differences in the management of coronary artery disease. N Engl J Med 1991;325:226-30.
40. Krumholz HM, Douglas PS, Luaer MS, et al. Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for gender bias? Ann Intern Med 1992;116:785-90.
41. Tu JV, Pashas CL, Naylor CD, et al. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med 1997;336:1500-5.
42. Rouleau JL, Moye LA, Pfeffer MA, et al, for the SAVE Investigators. A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med 1993;328:779-84.
43. Mark DB, Naylor CD, Hlatky MA, et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med 1994;331:1130-5.
44. MaClellan M, McNeil BJ, Newhouse JP, et al. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA 1994;272:859-66.
45. Lau J, Antman EM, Jimenez-Silva J, et al. Cumulative metaanalysis of therapeutic trials for myocardial infarction. N Engl J Med 1992;327:248-54.